Inflammatory bowel disease: clinical aspects and treatments

Marc Fakhoury,1 Rebecca Negrulj,2 Armin Mooranian,2 Hani Al-Salami2 1Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Center, Faculty of Medicine, McGill University, Montreal, QC, Canada; 2Biotechnology and Dru...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fakhoury M, Negrulj R, Mooranian A, Al-Salami H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/90850bf22a2745429eaad221be5035fe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:90850bf22a2745429eaad221be5035fe
record_format dspace
spelling oai:doaj.org-article:90850bf22a2745429eaad221be5035fe2021-12-02T04:59:26ZInflammatory bowel disease: clinical aspects and treatments1178-7031https://doaj.org/article/90850bf22a2745429eaad221be5035fe2014-06-01T00:00:00Zhttp://www.dovepress.com/inflammatory-bowel-disease-clinical-aspects-and-treatments-a17319https://doaj.org/toc/1178-7031 Marc Fakhoury,1 Rebecca Negrulj,2 Armin Mooranian,2 Hani Al-Salami2 1Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Center, Faculty of Medicine, McGill University, Montreal, QC, Canada; 2Biotechnology and Drug Development Research Laboratory, Curtin Health Innovation Research Institute, Biosciences Research Precinct, School of Pharmacy, Curtin University, Perth, WA, Australia Abstract: Inflammatory bowel disease (IBD) is defined as a chronic intestinal inflammation that results from host-microbial interactions in a genetically susceptible individual. IBDs are a group of autoimmune diseases that are characterized by inflammation of both the small and large intestine, in which elements of the digestive system are attacked by the body's own immune system. This inflammatory condition encompasses two major forms, known as Crohn's disease and ulcerative colitis. Patients affected by these diseases experience abdominal symptoms, including diarrhea, abdominal pain, bloody stools, and vomiting. Moreover, defects in intestinal epithelial barrier function have been observed in a number of patients affected by IBD. In this review, we first describe the types and symptoms of IBD and investigate the role that the epithelial barrier plays in the pathophysiology of IBD as well as the major cytokines involved. We then discuss steps used to diagnose this disease and the treatment options available, and finally provide an overview of the recent research that aims to develop new therapies for such chronic disorders. Keywords: inflammatory bowel disease, Crohn's disease, ulcerative colitis, cytokinesFakhoury MNegrulj RMooranian AAl-Salami HDove Medical PressarticlePathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol 2014, Iss default, Pp 113-120 (2014)
institution DOAJ
collection DOAJ
language EN
topic Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Fakhoury M
Negrulj R
Mooranian A
Al-Salami H
Inflammatory bowel disease: clinical aspects and treatments
description Marc Fakhoury,1 Rebecca Negrulj,2 Armin Mooranian,2 Hani Al-Salami2 1Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Center, Faculty of Medicine, McGill University, Montreal, QC, Canada; 2Biotechnology and Drug Development Research Laboratory, Curtin Health Innovation Research Institute, Biosciences Research Precinct, School of Pharmacy, Curtin University, Perth, WA, Australia Abstract: Inflammatory bowel disease (IBD) is defined as a chronic intestinal inflammation that results from host-microbial interactions in a genetically susceptible individual. IBDs are a group of autoimmune diseases that are characterized by inflammation of both the small and large intestine, in which elements of the digestive system are attacked by the body's own immune system. This inflammatory condition encompasses two major forms, known as Crohn's disease and ulcerative colitis. Patients affected by these diseases experience abdominal symptoms, including diarrhea, abdominal pain, bloody stools, and vomiting. Moreover, defects in intestinal epithelial barrier function have been observed in a number of patients affected by IBD. In this review, we first describe the types and symptoms of IBD and investigate the role that the epithelial barrier plays in the pathophysiology of IBD as well as the major cytokines involved. We then discuss steps used to diagnose this disease and the treatment options available, and finally provide an overview of the recent research that aims to develop new therapies for such chronic disorders. Keywords: inflammatory bowel disease, Crohn's disease, ulcerative colitis, cytokines
format article
author Fakhoury M
Negrulj R
Mooranian A
Al-Salami H
author_facet Fakhoury M
Negrulj R
Mooranian A
Al-Salami H
author_sort Fakhoury M
title Inflammatory bowel disease: clinical aspects and treatments
title_short Inflammatory bowel disease: clinical aspects and treatments
title_full Inflammatory bowel disease: clinical aspects and treatments
title_fullStr Inflammatory bowel disease: clinical aspects and treatments
title_full_unstemmed Inflammatory bowel disease: clinical aspects and treatments
title_sort inflammatory bowel disease: clinical aspects and treatments
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/90850bf22a2745429eaad221be5035fe
work_keys_str_mv AT fakhourym inflammatoryboweldiseaseclinicalaspectsandtreatments
AT negruljr inflammatoryboweldiseaseclinicalaspectsandtreatments
AT mooraniana inflammatoryboweldiseaseclinicalaspectsandtreatments
AT alsalamih inflammatoryboweldiseaseclinicalaspectsandtreatments
_version_ 1718400902344212480